Business · 09/03/2016
FDA Hosts Public Workshop on Liquid Chromatography-Mass Spectrometry Devices
The FDA is hosting a public workshop to discuss regulatory considerations for validating liquid chromatography-mass spectrometry based devices used in clinical laboratories, with a focus on protein- and peptide-based devices.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →